Zoulim F - Search Results

1

Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B.

Seignères B, Pichoud C, Ahmed SS, Hantz O, Trépo C, Zoulim F. Seignères B, et al. Among authors: zoulim f. J Infect Dis. 2000 Apr;181(4):1221-33. doi: 10.1086/315368. Epub 2000 Apr 13. J Infect Dis. 2000. PMID: 10762559 Clinical Trial.

2

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.

Zoulim F, Trépo C. Zoulim F, et al. J Hepatol. 1998 Jul;29(1):151-68. doi: 10.1016/s0168-8278(98)80191-8. J Hepatol. 1998. PMID: 9696505 Review. No abstract available.

3

Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance.

Pichoud C, Seignères B, Wang Z, Trépo C, Zoulim F. Pichoud C, et al. Among authors: zoulim f. Hepatology. 1999 Jan;29(1):230-7. doi: 10.1002/hep.510290119. Hepatology. 1999. PMID: 9862871

4

New antiviral agents for the therapy of chronic hepatitis B virus infection.

Zoulim F, Trepo C. Zoulim F, et al. Intervirology. 1999;42(2-3):125-44. doi: 10.1159/000024972. Intervirology. 1999. PMID: 10516467 Review.

5

Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.

Le Guerhier F, Pichoud C, Guerret S, Chevallier M, Jamard C, Hantz O, Li XY, Chen SH, King I, Trépo C, Cheng YC, Zoulim F. Le Guerhier F, et al. Among authors: zoulim f. Antimicrob Agents Chemother. 2000 Jan;44(1):111-22. doi: 10.1128/AAC.44.1.111-122.2000. Antimicrob Agents Chemother. 2000. PMID: 10602731 Free PMC article.

6

Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B.

Pichoud C, Berby F, Stuyver L, Petit MA, Trépo C, Zoulim F. Pichoud C, et al. Among authors: zoulim f. J Hepatol. 2000 Feb;32(2):307-16. doi: 10.1016/s0168-8278(00)80077-x. J Hepatol. 2000. PMID: 10707872

7

Design and evaluation of hepatitis B virus inhibitors.

Hantz O, Kraus JL, Zoulim F. Hantz O, et al. Among authors: zoulim f. Curr Pharm Des. 2000 Mar;6(5):503-23. doi: 10.2174/1381612003400740. Curr Pharm Des. 2000. PMID: 10788594 Review.

8

Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.

Nafa S, Ahmed S, Tavan D, Pichoud C, Berby F, Stuyver L, Johnson M, Merle P, Abidi H, Trépo C, Zoulim F. Nafa S, et al. Among authors: zoulim f. Hepatology. 2000 Nov;32(5):1078-88. doi: 10.1053/jhep.2000.19619. Hepatology. 2000. PMID: 11050059

9

Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo.

Seignères B, Aguesse-Germon S, Pichoud C, Vuillermoz I, Jamard C, Trépo C, Zoulim F. Seignères B, et al. Among authors: zoulim f. J Hepatol. 2001 Jan;34(1):114-22. doi: 10.1016/s0168-8278(00)00074-x. J Hepatol. 2001. PMID: 11211887

10

Viral hepatitis.

Trépo C, Zoulim F, Pradat P. Trépo C, et al. Among authors: zoulim f. Curr Opin Infect Dis. 1999 Oct;12(5):481-90. doi: 10.1097/00001432-199910000-00011. Curr Opin Infect Dis. 1999. PMID: 17035815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

621 results

Search Page